ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
22.839,03
-1,15%
S&P 500
5.717,46
-1,02%
Dow Jones
42.487,94
-0,23%
Euro vs US Dollar
1,07571
-0,27%
Bitcoin
86.702,98
-0,87%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Avadel Pharmaceuticals PLC (AVDL) Börsenkurse

Avadel Pharmaceuticals PLC

Avadel Pharmaceuticals PLC (AVDL)

NASDAQ
7,995
-0,205
( -2,50% )
Aktualisiert: 19:11:36
Verzögert um 15 Minuten
Fortg. Diagramm
Rendering Error

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
7,995
Gebot
7,99
Fragen
8,00
Volumen
380.993
7,98 Tagesbereich 8,30
7,39 52-Wochen-Bereich 19,09
Marktkapitalisierung
772,552M
Handelsende
8,20
Handelsbeginn
8,20
Letzte Trade
3
@
7.9975
Letzter Handelszeitpunkt
19:12:07
Finanzvolumen
US$ 3.078.382
VWAP
8,0799
Durchschnittliches Volumen (3 Mio.)
1.428.675
Ausgegebene Aktien
96.629.435
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
0,00
Gewinn pro Aktie (EPS)
-
Erlöse
169,12M
Nettogewinn
-48,83M

Über Avadel Pharmaceuticals PLC

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company markets products in bo... Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company markets products in both the primary care and sterile injectables markets. Its products portfolio includes Bloxiverz, Vazculep (phenylephrine hydrochloride injection), Akovaz (ephedrine sulfate injection), Karbinal ER (carbinoxamine maleate extended-release oral suspension), AcipHex Sprinkle (rabeprazole sodium), Cefaclor for Oral Suspension, 125 mg/5 mL, 250 mg/5 mL and 375 mg/5 mL, and Flexichamber. Majority of the revenue is derived from the United States. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.avadel.com
Hauptsitz
Dublin, Irl
Gegründet
-
Avadel Pharmaceuticals PLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AVDL. The last closing price for Avadel Pharmaceuticals was US$8,20. Over the last year, Avadel Pharmaceuticals shares have traded in a share price range of US$ 7,39 to US$ 19,09.

Avadel Pharmaceuticals currently has 96.629.435 shares in issue. The market capitalisation of Avadel Pharmaceuticals is US$792,36 million.

Option-Flow Avadel Pharmaceuticals (AVDL)

Vollständigen Option-Flow anzeigen

Gesamtfluss

Bullisch

Nettoprämie

27k

Calls / Puts

100,00%

Käuf. / Verkä.

100,00%

OTM / ITM

100,00%

Sweeps

0,00%

AVDL Neueste Nachrichten

Weitere Nachrichten

Form 8-K - Current report
Edgar (US Regulatory)
07 März 2025
AVDL (-2,50%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
07 März 2025
AVDL (-2,50%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
07 März 2025
AVDL (-2,50%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
03 März 2025
AVDL (-2,50%)

Form 8-K - Current report
Edgar (US Regulatory)
03 März 2025
AVDL (-2,50%)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.675-7.785467128038.678.87.987111248.56108298CS
4-0.115-1.418002466098.118.937.4511047898.04300212CS
12-2.515-23.929590865810.5111.527.3914286758.35921017CS
26-4.835-37.685113016412.8316.667.39126927410.26765382CS
52-8.685-52.068345323716.6819.097.39119335112.81241623CS
1560.99514.2142857143719.091.0511900999.34159511CS
260-0.785-8.940774487478.7819.091.059317119.0141919CS

AVDL - Frequently Asked Questions (FAQ)

What is the current Avadel Pharmaceuticals share price?
The current share price of Avadel Pharmaceuticals is US$ 7,995
How many Avadel Pharmaceuticals shares are in issue?
Avadel Pharmaceuticals has 96.629.435 shares in issue
What is the market cap of Avadel Pharmaceuticals?
The market capitalisation of Avadel Pharmaceuticals is USD 792,36M
What is the 1 year trading range for Avadel Pharmaceuticals share price?
Avadel Pharmaceuticals has traded in the range of US$ 7,39 to US$ 19,09 during the past year
What is the reporting currency for Avadel Pharmaceuticals?
Avadel Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Avadel Pharmaceuticals?
The latest annual turnover of Avadel Pharmaceuticals is USD 169,12M
What is the latest annual profit for Avadel Pharmaceuticals?
The latest annual profit of Avadel Pharmaceuticals is USD -48,83M
What is the registered address of Avadel Pharmaceuticals?
The registered address for Avadel Pharmaceuticals is 10 EARLSFORT TERRACE, DUBLIN, D02 T380
What is the Avadel Pharmaceuticals website address?
The website address for Avadel Pharmaceuticals is www.avadel.com
Which industry sector does Avadel Pharmaceuticals operate in?
Avadel Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
PTPIPetros Pharmaceuticals Inc
US$ 0,1763
(205,02%)
1,42B
OCEAOcean Biomedical Inc
US$ 0,1245
(119,19%)
696,95M
OSRHOSR Holdings Inc
US$ 3,43
(114,38%)
77,39M
VVPRVivoPower International PLC
US$ 3,7501
(65,93%)
133,48M
SURGSurgePays Inc
US$ 2,2208
(60,93%)
64,91M
BACKIMAC Holdings Inc
US$ 0,071
(-64,50%)
1,15M
ACRVAcrivon Therapeutics Inc
US$ 3,02
(-43,97%)
1,07M
BHILBenson Hill Inc
US$ 0,25505
(-39,76%)
975,14k
TNONTenon Medical Inc
US$ 2,4677
(-34,19%)
16,86M
HUMAHumacyte Inc
US$ 2,015
(-29,91%)
20,5M
PTPIPetros Pharmaceuticals Inc
US$ 0,1763
(205,02%)
1,42B
OCEAOcean Biomedical Inc
US$ 0,1245
(119,19%)
696,95M
LYTLytus Technologies Holdings PTV Ltd
US$ 0,0792
(56,52%)
270,35M
NVDANVIDIA Corporation
US$ 112,955
(-6,41%)
206,09M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10,40
(-12,24%)
178,61M

AVDL Finanzen

Finanzen
Rendering Error

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
AVDL
Avadel Pharmaceuticals
BIT
P1SG53
BNP Paribas Issuance
USOTC
FHSEY
First HighSchool Education (QB)
Delayed Upgrade Clock
ADVFN Logo
Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten